Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 21
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
AnaptysBio Inc
ANAB
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$48.12
2.69
5.92%
Últ. Act.: Oct 21, 10:38 AM
$44.60
-0.83
-1.83%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Privacy Manager
AnaptysBio Financials
AnaptysBio (ANAB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.46) by 76.09 percent. This is a 91.79 percent increase over losses of $(1.34) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q1 EPS $(1.84) Misses $(0.92) Estimate, Sales $25.556M Miss $28.973M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.92) by 100 percent. This is a 43.75 percent decrease over losses of $(1.28) per share from the
Benzinga Newsdesk
PRO
CORRECTION: AnaptysBio Q4 EPS $1.58 Beats $0.80 Estimate, Sales $108.240M Beat $92.051M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $0.80 by 98.49 percent. This is a 319.44 percent increase over losses of $(0.72) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q3 EPS $0.52 Beats $(1.42) Estimate, Sales $76.320M Beat $15.811M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $(1.42) by 136.65 percent. This is a 145.61 percent increase over losses of $(1.14) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q2 EPS $(1.34) Beats $(1.52) Estimate, Sales $22.263M Beat $11.552M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.34) per share which beat the analyst consensus estimate of $(1.52) by 11.61 percent. This is a 21.64 percent increase over losses of $(1.71) per share from the
Benzinga Newsdesk
Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May
Avi Kapoor
